Addiction as a stress surfeit disorder

Neuropharmacology

Volumn 76, Issue PART B, 2014, Pages 370-382

  Koob, George F ^a   Buck, Cara L ^a   Cohen, Ami ^a   Edwards, Scott ^a   Park, Paula E ^a   Schlosburg, Joel E ^a   Schmeichel, Brooke ^a   Vendruscolo, Leandro F ^a   Wade, Carrie L ^a   Whitfield, Timothy W ^a   George, Olivier ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Abstinence or withdrawal; Compulsive; Corticotropin releasing factor; Dynorphin; Extended amygdala; Impulsive; Opponent process; Prefrontal cortex; Reward; Sensitization

Indexed keywords

ALCOHOL; COCAINE; CORTICOTROPIN RELEASING FACTOR; DIAMORPHINE; DOPAMINE; DOPAMINE RECEPTOR; DYNORPHIN; KAPPA OPIATE RECEPTOR; METHAMPHETAMINE; NICOTINE; OPIATE RECEPTOR;

ABSTINENCE; ADDICTION; AMYGDALOID NUCLEUS; ANXIETY; COMPULSION; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG SEEKING BEHAVIOR; DRUG SENSITIZATION; EMOTION; EXECUTIVE FUNCTION; FRONTAL CORTEX; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; STAGING; STRESS; STRESS SURFEIT DISORDER; WITHDRAWAL SYNDROME;

ABSTINENCE OR WITHDRAWAL; COMPULSIVE; CORTICOTROPIN-RELEASING FACTOR; DYNORPHIN; EXTENDED AMYGDALA; IMPULSIVE; OPPONENT PROCESS; PREFRONTAL CORTEX; REWARD; SENSITIZATION;

AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DRUG-SEEKING BEHAVIOR; DYNORPHINS; HUMANS; IMPULSIVE BEHAVIOR; PREFRONTAL CORTEX; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS;

EID: 84887056176     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.05.024     Document Type: Review

References (157)

1. S.H. Ahmed, and M. Cador Dissociation of psychomotor sensitization from compulsive cocaine consumption Neuropsychopharmacology 31 2006 563 571 (Pubitemid 43276972)
2. S.H. Ahmed, P.J. Kenny, G.F. Koob, and A. Markou Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat. Neurosci. 5 2002 625 626 (Pubitemid 34742974)
3. S.H. Ahmed, and G.F. Koob Transition from moderate to excessive drug intake: change in hedonic set point Science 282 1998 298 300 (Pubitemid 28487203)
4. S.H. Ahmed, and G.F. Koob Long-lasting increase in the set point for cocaine self-administration after escalation in rats Psychopharmacology 146 1999 303 312 (Pubitemid 29480242)
5. S.H. Ahmed, J.R. Walker, and G.F. Koob Persistent increase in the motivation to take heroin in rats with a history of drug escalation Neuropsychopharmacology 22 2000 413 421 (Pubitemid 30105769)
6. G.F. Alheid, J.S. De Olmos, and C.A. Beltramino Amygdala and extended amygdala G. Paxinos, The Rat Nervous System 1995 Academic Press San Diego 495 578
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. 1994 American Psychiatric Press Washington DC
8. G. Aston-Jones, J.M. Delfs, J. Druhan, and Y. Zhu The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal J.F. McGinty, Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse Annals of the New York Academy of Sciences vol. 877 1999 New York Academy of Sciences New York 486 498 (Pubitemid 29351874)
9. T.B. Baker, M.E. Piper, D.E. McCarthy, M.R. Majeskie, and M.C. Fiore Addiction motivation reformulated: an affective processing model of negative reinforcement Psychol. Rev. 111 2004 33 51 (Pubitemid 38157073)
10. H.A. Baldwin, S. Rassnick, J. Rivier, G.F. Koob, and K.T. Britton CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat Psychopharmacology 103 1991 227 232
11. E. Barbier, L.F. Vendruscolo, J.E. Schlosburg, S. Edwards, N. Juergens, P.E. Park, K.K. Misra, K. Cheng, K.C. Rice, J. Schank, G. Schulteis, G.F. Koob, and M. Heilig The NK1 receptor antagonist L822429 reduces heroin reinforcement Neuropsychopharmacology 2013 (in press)
12. A.M. Basso, M. Spina, J. Rivier, W. Vale, and G.F. Koob Corticotropin-releasing factor antagonist attenuates the "anxiogenic- like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats Psychopharmacology 145 1999 21 30 (Pubitemid 29339759)
13. P.M. Beardsley, J.L. Howard, K.L. Shelton, and F.I. Carroll Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats Psychopharmacology 183 2005 118 126 (Pubitemid 41484188)
14. O. Ben-Shahar, S.H. Ahmed, G.F. Koob, and A. Ettenberg The transition from controlled to compulsive drug use is associated with a loss of sensitization Brain Res. 995 2004 46 54 (Pubitemid 37486014)
15. O. Ben-Shahar, E.J. Posthumus, S.A. Waldroup, and A. Ettenberg Heightened drug-seeking motivation following extended daily access to self-administered cocaine Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 863 869 (Pubitemid 351312388)
16. C.O. Boyson, T.T. Miguel, I.M. Quadros, J.F. Debold, and K.A. Miczek Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA Psychopharmacology 218 2011 257 269
17. 1a-receptor agonist Neuropsychopharmacology 30 2005 1662 1669 (Pubitemid 43086023)
18. L.A. Briand, S.B. Flagel, M.J. Garcia-Fuster, S.J. Watson, H. Akil, M. Sarter, and T.E. Robinson Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine Neuropsychopharmacology 33 2008 2969 2980
19. L.A. Briand, J.P. Gross, and T.E. Robinson Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration Neuroscience 155 2008 1 6
20. A.W. Bruijnzeel, E. Small, T.M. Pasek, and H. Yamada Corticotropin- releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats Behav. Brain Res. 210 2010 288 291
21. A.W. Bruijnzeel, G. Zislis, C. Wilson, and M.S. Gold Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats Neuropsychopharmacology 32 2007 955 963 (Pubitemid 46426186)
22. W.A. Carlezon Jr., J. Thome, V.G. Olson, S.B. Lane-Ladd, E.S. Brodkin, N. Hiroi, R.S. Duman, R.L. Neve, and E.J. Nestler Regulation of cocaine reward by CREB Science 282 1998 2272 2275 (Pubitemid 29004079)
23. E. Chartoff, A. Sawyer, A. Rachlin, D. Potter, A. Pliakas, and W.A. Carlezon Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats Neuropharmacology 62 2012 1167 1176
24. C. Chavkin, I.F. James, and A. Goldstein Dynorphin is a specific endogenous ligand of the κ opioid receptor Science 215 1982 413 415 (Pubitemid 12132127)
25. A. Cohen, G.F. Koob, and O. George Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence Neuropsychopharmacology 37 2012 2153 2160
26. F.C. Colpaert System theory of pain and of opiate analgesia: no tolerance to opiates Pharmacol. Rev. 48 1996 355 402 (Pubitemid 26325802)
27. A. Contarino, and F. Papaleo The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal Proc. Natl. Acad. Sci. U. S. A. 102 2005 18649 18654 (Pubitemid 43011280)
28. J.M. Delfs, Y. Zhu, J.P. Druhan, and G. Aston-Jones Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion Nature 403 2000 430 434 (Pubitemid 30073092)
29. V. Deroche, M. Le Moal, and P.V. Piazza Cocaine self-administration increases the incentive motivational properties of the drug in rats Eur. J. Neurosci. 11 1999 2731 2736 (Pubitemid 29364189)
30. V. Deroche-Gamonet, D. Belin, and P.V. Piazza Evidence for addiction-like behavior in the rat Science 305 2004 1014 1017 (Pubitemid 39071778)
31. A.J. Dunn, and C.W. Berridge Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15 1990 71 100
32. 1b receptors mediate the transition to excessive drinking in ethanol-dependent rats Addict. Biol. 17 2011 76 85
33. M.P. Epping-Jordan, S.S. Watkins, G.F. Koob, and A. Markou Dramatic decreases in brain reward function during nicotine withdrawal Nature 393 1998 76 79 (Pubitemid 28240257)
34. J.H. Fallon, and F.M. Leslie Distribution of dynorphin and enkephalin peptides in the rat brain J. Comp. Neurol. 249 1986 293 336 (Pubitemid 16059334)
35. C.K. Funk, L.E. O'Dell, E.F. Crawford, and G.F. Koob Corticotropin- releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats J. Neurosci. 26 2006 11324 11332 (Pubitemid 44772162)
36. C.K. Funk, E.P. Zorrilla, M.J. Lee, K.C. Rice, and G.F. Koob Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats Biol. Psychiatry 61 2007 78 86 (Pubitemid 44855743)
37. E.L. Gardner, and S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol. Dis. 5 1998 502 533 (Pubitemid 29075848)
38. D.R. Gehlert, A. Cippitelli, A. Thorsell, A.D. Le, P.A. Hipskind, C. Hamdouchi, J. Lu, E.J. Hembre, J. Cramer, M. Song, D. McKinzie, M. Morin, R. Ciccocioppo, and M. Heilig 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1- ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism J. Neurosci. 27 2007 2718 2726 (Pubitemid 46393604)
39. 1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats Proc. Natl. Acad. Sci. U. S. A. 104 2007 17198 17203 (Pubitemid 350211014)
40. O. George, C.D. Mandyam, S. Wee, and G.F. Koob Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments Neuropsychopharmacology 33 2008 2474 2482
41. O. George, C. Sanders, J. Freiling, E. Grigoryan, S. Vu, C.D. Allen, E. Crawford, C.D. Mandyam, and G.F. Koob Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking Proc. Natl. Acad. Sci. U. S. A. 109 2012 18156 18161
42. A.M. Gray, S.M. Rawls, T.S. Shippenberg, and J.F. McGinty The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum J. Neurochem. 73 1999 1066 1074 (Pubitemid 29395463)
43. T.N. Greenwell, C.K. Funk, P. Cottone, H.N. Richardson, S.A. Chen, K. Rice, E.P. Zorrilla, and G.F. Koob Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long-, but not short-access rats Addict. Biol. 14 2009 130 143
44. T.H. Hand, G.F. Koob, L. Stinus, and M. Le Moal Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats Brain Res. 474 1988 364 368
45. A.C. Harris, P.R. Pentel, D. Burroughs, M.D. Staley, and M.G. Lesage A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats Psychopharmacology 217 2011 153 166
46. M. Heilig The NPY system in stress, anxiety and depression Neuropeptides 38 2004 213 224 (Pubitemid 39158860)
47. L. Heimer, and G. Alheid Piecing together the puzzle of basal forebrain anatomy T.C. Napier, P.W. Kalivas, I. Hanin, The Basal Forebrain: Anatomy to Function Advances in Experimental Medicine and Biology vol. 295 1991 Plenum Press New York 1 42
48. S.C. Heinrichs, F. Menzaghi, G. Schulteis, G.F. Koob, and L. Stinus Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal Behav. Pharmacol. 6 1995 74 80
49. G.O. Hjelmstad, and H.L. Fields Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell J. Neurophysiol. 85 2001 1153 1158 (Pubitemid 32209601)
50. M.M. Huang, D.H. Overstreet, D.J. Knapp, R. Angel, T.A. Wills, M. Navarro, J. Rivier, W. Vale, and G.R. Breese Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization J. Pharmacol. Exp. Ther. 332 2010 298 307
51. P.A. Iredale, J.D. Alvaro, Y. Lee, R. Terwilliger, Y.L. Chen, and R.S. Duman Role of corticotropin-releasing factor receptor-1 in opiate withdrawal J. Neurochem. 74 2000 199 208 (Pubitemid 30012770)
52. K.J. Jackson, J.P. McLaughlin, F.I. Carroll, and M.I. Damaj Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice Psychopharmacology (Berl) 226 2013 763 768
53. W. James The Principles of Psychology 1918 Dover Publications New York
54. C.G. Jang, T. Whitfield, G. Schulteis, G.F. Koob, and S. Wee Sensitization of a negative emotional-like state during repeated withdrawal from extended access methamphetamine self-administration in rats Psychopharmacology 225 2013 753 763
55. S. Jonkman, Y. Pelloux, and B.J. Everitt Drug intake is sufficient, but conditioning is not necessary for the emergence of compulsive cocaine seeking after extended self-administration Neuropsychopharmacology 37 2012 1612 1619
56. M. Kallupi, S. Wee, S. Edwards, T.W. Whitfield Jr., C.S. Oleata, G. Luu, B.E. Schmeichel, G.F. Koob, and M. Roberto Kappa opioid receptor-mediated dysregulation of GABAergic transmission in the central amygdala in cocaine addiction Biol. Psychiatry 2013 (in press)
57. P.J. Kenny, S.A. Chen, O. Kitamura, A. Markou, and G.F. Koob Conditioned withdrawal drives heroin consumption and decreases reward sensitivity J. Neurosci. 26 2006 5894 5900 (Pubitemid 44318354)
58. P.J. Kenny, I. Polis, G.F. Koob, and A. Markou Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats Eur. J. Neurosci. 17 2003 191 195 (Pubitemid 36098891)
59. E.J. Khantzian The self-medication hypothesis of substance use disorders: a reconsideration and recent applications Harv. Rev. Psychiatry 4 1997 231 244 (Pubitemid 27086599)
60. O. Kitamura, S. Wee, S.E. Specio, G.F. Koob, and L. Pulvirenti Escalation of methamphetamine self-administration in rats: a dose-effect function Psychopharmacology 186 2006 48 53 (Pubitemid 43668310)
61. L.A. Knackstedt, and P.W. Kalivas Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization J. Pharmacol. Exp. Ther. 322 2007 1103 1109 (Pubitemid 47295776)
62. D.J. Knapp, D.H. Overstreet, S.S. Moy, and G.R. Breese SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats Alcohol 32 2004 101 111 (Pubitemid 38668688)
63. A.T. Knoll, and W.A. Carlezon Jr. Dynorphin, stress, and depression Brain Res. 1314 2010 56 73
64. A.T. Knoll, E.G. Meloni, J.B. Thomas, F.I. Carroll, and W.A. Carlezon Jr. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats J. Pharmacol. Exp. Ther. 323 2007 838 845 (Pubitemid 350146065)
65. G.F. Koob Neuroadaptive mechanisms of addiction: studies on the extended amygdala Eur. Neuropsychopharmacol. 13 2003 442 452 (Pubitemid 37433964)
66. G.F. Koob A role for brain stress systems in addiction Neuron 59 2008 11 34 (Pubitemid 351905857)
67. G.F. Koob Neurobiological substrates for the dark side of compulsivity in addiction Neuropharmacology 56 2009 18 31
68. G.F. Koob Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction: alcohol addiction as a reward deficit disorder W.H. Sommer, R. Spanagel, Behavioral Neurobiology of Alcohol Addiction Current Topics in Behavioral Neuroscience vol. 13 2012 Springer-Verlag Berlin 3 30
69. G.F. Koob, T. Bartfai, and A.J. Roberts The use of molecular genetic approaches in the neuropharmacology of corticotropin-releasing factor Int. J. Comp. Psychol. 14 2001 90 110
70. G.F. Koob, and F.E. Bloom Cellular and molecular mechanisms of drug dependence Science 242 1988 715 723
71. G.F. Koob, and S.C. Heinrichs A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors Brain Res. 848 1999 141 152 (Pubitemid 30001663)
72. G.F. Koob, S.C. Heinrichs, F. Menzaghi, E.M. Pich, and K.T. Britton Corticotropin releasing factor, stress and behavior Semin. Neurosci. 6 1994 221 229 (Pubitemid 24310596)
73. G.F. Koob, and M.J. Kreek Stress, dysregulation of drug reward pathways, and the transition to drug dependence Am. J. Psychiatry 164 2007 1149 1159 (Pubitemid 47292402)
74. G.F. Koob, and M. Le Moal Drug abuse: hedonic homeostatic dysregulation Science 278 1997 52 58 (Pubitemid 27446270)
75. G.F. Koob, and M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97 129
76. G.F. Koob, and M. Le Moal Addiction and the brain antireward system Annu. Rev. Psychol. 59 2008 29 53
77. G.F. Koob, L. Stinus, M. Le Moal, and F.E. Bloom Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence Neurosci. Biobehav. Rev. 13 1989 135 140 (Pubitemid 19241928)
78. B.B. Land, M.R. Bruchas, J.C. Lemos, M. Xu, E.J. Melief, and C. Chavkin The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J. Neurosci. 28 2008 407 414
79. B.B. Land, M.R. Bruchas, S. Schattauer, W.J. Giardino, M. Aita, D. Messinger, T.S. Hnasko, R.D. Palmiter, and C. Chavkin Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking Proc. Natl. Acad. Sci. U. S. A. 106 2009 19168 19173
80. J.C. Lemos, M.J. Wanat, J.S. Smith, B.A. Reyes, N.G. Hollon, E.J. Van Bockstaele, C. Chavkin, and P.E. Phillips Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive Nature 490 2012 402 406
81. J. Liu, and G. Schulteis Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence Pharmacol. Biochem. Behav. 79 2004 101 108 (Pubitemid 39237708)
82. S.D. Mague, A.M. Pliakas, M.S. Todtenkopf, H.C. Tomasiewicz, Y. Zhang, W.C. Stevens Jr., R.M. Jones, P.S. Portoghese, and W.A. Carlezon Jr. Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats J. Pharmacol. Exp. Ther. 305 2003 323 330 (Pubitemid 36373867)
83. S.F. Maier, and L.R. Watkins Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor Neurosci. Biobehav. Rev. 29 2005 829 841 (Pubitemid 40762600)
84. J.R. Mantsch, V. Yuferov, A.M. Mathieu-Kia, A. Ho, and M.J. Kreek Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats Psychopharmacology 175 2004 26 36 (Pubitemid 39215527)
85. C.A. Marcinkiewcz, M.M. Prado, S.K. Isaac, A. Marshall, D. Rylkova, and A.W. Bruijnzeel Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats Neuropsychopharmacology 34 2009 1743 1752
86. E.B. Margolis, H. Lock, V.I. Chefer, T.S. Shippenberg, G.O. Hjelmstad, and H.L. Fields Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex Proc. Natl. Acad. Sci. U. S. A. 103 2006 2938 2942
87. A. Markou, and G.F. Koob Post-cocaine anhedonia: an animal model of cocaine withdrawal Neuropsychopharmacology 4 1991 17 26
88. B.S. McEwen Allostasis and allostatic load: implications for neuropsychopharmacology Neuropsychopharmacology 22 2000 108 124
89. J.P. McLaughlin, S. Li, J. Valdez, T.A. Chavkin, and C. Chavkin Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system Neuropsychopharmacology 31 2006 1241 1248 (Pubitemid 43971840)
90. J.P. McLaughlin, M. Marton-Popovici, and C. Chavkin κ Opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses J. Neurosci. 23 2003 5674 5683 (Pubitemid 36807845)
91. E. Merlo-Pich, M. Lorang, M. Yeganeh, F. Rodriguez de Fonseca, J. Raber, G.F. Koob, and F. Weiss Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis J. Neurosci. 15 1995 5439 5447
92. R.F. Mucha, and A. Herz Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning Psychopharmacology 86 1985 274 280 (Pubitemid 15064950)
93. J. Navarro-Zaragoza, C. Núñez, M.L. Laorden, and M.V. Milanés Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal Mol. Pharmacol. 77 2010 864 873
94. K.A. Nealey, A.W. Smith, S.M. Davis, D.G. Smith, and B.M. Walker Kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol- dependent rats Neuropharmacology 61 2011 35 42
95. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128 (Pubitemid 33673366)
96. E.J. Nestler Historical review: molecular and cellular mechanisms of opiate and cocaine addiction Trends Pharmacol. Sci. 25 2004 210 218 (Pubitemid 38519912)
97. V. Neugebauer, W. Li, G.C. Bird, and J.S. Han The amygdala and persistent pain Neuroscientist 10 2004 221 234 (Pubitemid 38678530)
98. L.E. O'Dell, A.J. Roberts, R.T. Smith, and G.F. Koob Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure Alcohol. Clin. Exp. Res. 28 2004 1676 1682 (Pubitemid 39551828)
99. M.F. Olive, H.N. Koenig, M.A. Nannini, and C.W. Hodge Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake Pharmacol. Biochem. Behav. 72 2002 213 220 (Pubitemid 34251330)
100. 1 receptors Pharmacol. Biochem. Behav. 77 2004 405 413 (Pubitemid 38125175)
101. D.H. Overstreet, D.J. Knapp, and G.R. Breese Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats Alcohol. Clin. Exp. Res. 31 2007 1473 1481 (Pubitemid 47319653)
102. N.E. Paterson, and A. Markou Increased motivation for self-administered cocaine after escalated cocaine intake Neuroreport 14 2003 2229 2232
103. N.E. Paterson, C. Myers, and A. Markou Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats Psychopharmacology 152 2000 440 446
104. M.A. Pelleymounter, M. Joppa, M. Carmouche, M.J. Cullen, B. Brown, B. Murphy, D.E. Grigoriadis, N. Ling, and A.C. Foster Role of corticotropin- releasing factor (CRF) receptors in the anorexic syndrome induced by CRF J. Pharmacol. Exp. Ther. 293 2000 799 806 (Pubitemid 30417844)
105. Y. Pelloux, B.J. Everitt, and A. Dickinson Compulsive drug seeking by rats under punishment: effects of drug taking history Psychopharmacology 194 2007 127 137 (Pubitemid 47282729)
106. A. Pfeiffer, V. Brantl, A. Herz, and H.M. Emrich Psychotomimesis mediated by κ opiate receptors Science 233 1986 774 776
107. A.M. Pliakas, R.R. Carlson, R.L. Neve, C. Konradi, E.J. Nestler, and W.A. Carlezon Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens J. Neurosci. 21 2001 7397 7403 (Pubitemid 32846987)
108. I.M. Quadros, and K.A. Miczek Two modes of intense cocaine bingeing: increased persistence after social defeat stress and increased rate of intake due to extended access conditions in rats Psychopharmacology 206 2009 109 120
109. D.G. Rainnie, R. Bergeron, T.J. Sajdyk, M. Patil, D.R. Gehlert, and A. Shekhar Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders J. Neurosci. 24 2004 3471 3479 (Pubitemid 38481103)
110. D.D. Rasmussen, B.M. Boldt, C.A. Bryant, D.R. Mitton, S.A. Larsen, and C.W. Wilkinson Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis Alcohol. Clin. Exp. Res. 24 2000 1836 1849 (Pubitemid 32001855)
111. S. Rassnick, S.C. Heinrichs, K.T. Britton, and G.F. Koob Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal Brain Res. 605 1993 25 32 (Pubitemid 23083057)
112. V.A. Redila, and C. Chavkin Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system Psychopharmacology 200 2008 59 70
113. 1) antagonist Pharmacol. Biochem. Behav. 88 2008 497 510 (Pubitemid 350266794)
114. R. Rimondini, C. Arlinde, W. Sommer, and M. Heilig Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol FASEB J. 16 2002 27 35 (Pubitemid 34027947)
115. C. Rivier, T. Bruhn, and W. Vale Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF) J. Pharmacol. Exp. Ther. 229 1984 127 131 (Pubitemid 14082921)
116. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Rev. 18 1993 247 291 (Pubitemid 23219500)
117. M.A.H. Russell What is dependence? G. Edwards, Drugs and Drug Dependence 1976 Lexington Books Lexington MA 182 187
118. Z. Sarnyai, E. Biro, J. Gardi, M. Vecsernyes, J. Julesz, and G. Telegdy Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats Brain Res. 675 1995 89 97
119. Z. Sarnyai, Y. Shaham, and S.C. Heinrichs The role of corticotropin-releasing factor in drug addiction Pharmacol. Rev. 53 2001 209 243 (Pubitemid 32476116)
120. A.G. Schindler, S. Li, and C. Chavkin Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms Neuropsychopharmacology 35 2010 1932 1942
121. J.E. Schlosburg, L.F. Vendruscolo, P.E. Park, T.W. Whitfield Jr., and G.F. Koob Long-term antagonism of kappa opioid receptors prevents escalation of, and increased motivation for, heroin intake Soc. Neurosci. 2011 Abstracts, abstr# 16.07
122. G. Schulteis, and J. Liu Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats Alcohol 39 2006 21 28 (Pubitemid 44287278)
123. G. Schulteis, A. Markou, M. Cole, and G. Koob Decreased brain reward produced by ethanol withdrawal Proc. Natl. Acad. Sci. U. S. A. 92 1995 5880 5884
124. G. Schulteis, A. Markou, L.H. Gold, L. Stinus, and G.F. Koob Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis J. Pharmacol. Exp. Ther. 271 1994 1391 1398 (Pubitemid 24382650)
125. T.S. Shippenberg, A. Zapata, and V.I. Chefer Dynorphin and the pathophysiology of drug addiction Pharmacol. Ther. 116 2007 306 321 (Pubitemid 47454747)
126. J. Shurman, G.F. Koob, and H.B. Gutstein Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain Pain Med. 11 2010 1092 1098
127. N. Sidhpura, and L.H. Parsons Endocannabinoid-mediated synaptic plasticity and addiction-related behavior Neuropharmacology 61 2011 1070 1087
128. K.S. Sink, D.L. Walker, S.M. Freeman, E.I. Flandreau, K.J. Ressler, and M. Davis Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety Mol. Psychiatry 18 2013 308 319
129. R.L. Solomon, and J.D. Corbit An opponent-process theory of motivation: 1. Temporal dynamics of affect Psychol. Rev. 81 1974 119 145
130. 1 receptor antagonists attenuate escalated cocaine self-administration in rats Psychopharmacology 196 2008 473 482 (Pubitemid 351191180)
131. M. Spina, E. Merlo-Pich, R.K.W. Chan, A.M. Basso, J. Rivier, W. Vale, and G.F. Koob Appetite-suppressing effects of urocortin, a CRF-related neuropeptide Science 273 1996 1561 1564 (Pubitemid 26301669)
132. L. Stinus, M. Cador, E.P. Zorrilla, and G.F. Koob Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats Neuropsychopharmacology 30 2005 90 98 (Pubitemid 40024403)
133. L. Stinus, M. Le Moal, and G.F. Koob Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal Neuroscience 37 1990 767 773 (Pubitemid 20282214)
134. L.W. Swanson, P.E. Sawchenko, J. Rivier, and W. Vale The organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study Neuroendocrinology 36 1983 165 186 (Pubitemid 13138041)
135. 2 receptors produces anxiolytic behavior in animal models of anxiety Brain Res. 902 2001 135 142 (Pubitemid 32510861)
136. H.A. Tejeda Modulation of extracellular dopamine in the prefrontal cortex by local and ventral tegmental area kappa-opioid receptors Soc. Neurosci. 2009 Abstr. abstr# 751.7
137. H.A. Tejeda, L.A. Natividad, J.E. Orfila, O.V. Torres, and L.E. O'Dell Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner Psychopharmacology (Berl) 224 2012 289 301
138. M.S. Todtenkopf, J.F. Marcus, P.S. Portoghese, and W.A. Carlezon Jr. Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats Psychopharmacology 172 2004 463 470 (Pubitemid 38650984)
139. 9-41, reverses nicotine-induced conditioned, but not unconditioned, anxiety Psychopharmacology 167 2003 251 256 (Pubitemid 36712971)
140. A.V. Turnbull, and C. Rivier Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides Proc. Natl. Acad. Sci. U. S. A. 215 1997 1 10
141. G.R. Valdez, D.M. Platt, J.K. Rowlett, D. Rüedi-Bettschen, and R.D. Spealman κ Agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms J. Pharmacol. Exp. Ther. 323 2007 525 533 (Pubitemid 350005110)
142. G.R. Valdez, V. Sabino, and G.F. Koob Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation Alcohol. Clin. Exp. Res. 28 2004 865 872 (Pubitemid 38780564)
143. G.R. Valdez, E.P. Zorrilla, A.J. Roberts, and G.F. Koob Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence Alcohol 29 2003 55 60 (Pubitemid 36623341)
144. L.J. Vanderschuren, and B.J. Everitt Drug seeking becomes compulsive
145. L. Vendruscolo, J.E. Schlosburg, K.K. Misra, S.A. Chen, T.N. Greenwell, and G.F. Koob Escalation patterns of varying periods of heroin access Pharmacol. Biochem. Behav. 98 2011 570 574
146. L.F. Vendruscolo, E. Barbier, J.E. Schlosburg, K.K. Misra, T. Whitfield Jr., M.L. Logrip, C.L. Rivier, V. Repunte-Canonigo, E.P. Zorrilla, P.P. Sanna, M. Heilig, and G.F. Koob Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats J. Neurosci. 32 2012 7563 7571
147. P. Vezina Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs Neurosci. Biobehav. Rev. 27 2004 827 839 (Pubitemid 38199613)
148. N.D. Volkow, J.S. Fowler, and G.J. Wang The addicted human brain: insights from imaging studies J. Clin. Invest. 111 2003 1444 1451 (Pubitemid 38063274)
149. B.M. Walker, and G.F. Koob The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats Alcohol. Clin. Exp. Res. 31 2007 11 18 (Pubitemid 46025360)
150. B.M. Walker, E.P. Zorrilla, and G.F. Koob Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats Addict. Biol. 16 2010 116 119
151. S.J. Watson, H. Khachaturian, H. Akil, D.H. Coy, and A. Goldstein Comparison of the distribution of dynorphin systems and enkephalin systems in brain Science 218 1982 1134 1136 (Pubitemid 13223318)
152. S. Wee, and G.F. Koob The role of the dynorphin-κ opioid system in the reinforcing effects of drugs of abuse Psychopharmacology 210 2010 121 135
153. 1- Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access Eur. Neuropsychopharmacol. 18 2008 303 311 (Pubitemid 351246717)
154. S. Wee, L. Orio, S. Ghirmai, J.R. Cashman, and G.F. Koob Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine Psychopharmacology 205 2009 565 575
155. 2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged access Neuropsychopharmacology 32 2007 2238 2247 (Pubitemid 47417701)
156. T.W. Whitfield Jr., S. Wee, A. Gould, J. Schlosburg, L. Vendruscolo, and G.F. Koob Kappa receptor activation underlies compulsive methamphetamine intake Soc. Neurosci. 2011 Abstracts abstr# 797.19
157. T.A. Wills, D.J. Knapp, D.H. Overstreet, and G.R. Breese Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats Alcohol. Clin. Exp. Res. 33 2009 455 463